Posts Tagged ‘cannabis’

https://www.sciencedaily.com/releases/2018/05/180510145924.htm

 

AuntieBS

Advertisements

https://www.sciencedaily.com/releases/2018/05/180510162925.htm

There is a lot of anecodotal evidence as to cannabis action against cancers of various kinds.  And, this is furthere supported by scientific research showing that a type of brain cancer, glioma, is indeed killed by cannabis, in vitro, at least.

Until Big Pharms stops trying to interfere in research, and our politicians remove their heads from the lobbyist’s behinds, there can be no legal research in this country because cannabis is scheduled I, along with heroin, methamphetamine, and crack cocaine.

AuntieBS

Study: Cannabis Use Associated With Lower Risk Of Atrial Fibrillation Among Patients Hospitalized For Heart Failure

Cannabis Use Lower Risk Of Atrial FibrillationEnglewood, NJ: Cannabis exposure is associated with lower instances of atrial fibrillation (arrhythmia) in patients hospitalized for heart failure, according to data published in the American Journal of Cardiology.

A team of investigators from Seton Hall University, the University of Alabama at Birmingham, and elsewhere assessed the relationship between cannabis exposure and atrial fibrillation in a cohort of nearly four million patients hospitalized in 2014 for heart failure.

Compared to matched controls, “Cannabis users have lower odds of AF [than do] nonusers, which was not explained by co-morbid conditions, age, insurance type, [or] socioeconomic status,” authors concluded.

A prior analysis by the team similarly reported that cannabis exposure lowered the risk of atrial fibrillation and also reduced in-hospital mortality in heart failure patients.

Other studies have similarly reported that marijuana-exposed patients are less likely than non-users to die when hospitalized for burns and other forms of severe trauma, certain types of orthopedic surgeries, and traumatic brain injury.

For more information, contact Paul Armentano, NORML Deputy Director, at: paul@norml.org. Full text of the study, “Relation of cannabis use and atrial fibrillation among patients hospitalized for heart failure,” appears in the American Journal of Cardiology.

https://www.sciencedaily.com/releases/2018/05/180501085137.htm

Study shows up to 65 percent of older adults who use medical marijuana significantly reduced their chronic pain and dependence on opioid painkillers

I am aware of people who ate cannabis (~20-30g THC) in lieu of taking opiates when recovering from joint replacement surgeries.  They all touted longer relief (sleeping the night through instead of waking in pain and needing more opiates), as well as less constipation that opiates cause.  Most only used the cannabis at night, while continuing opiates during the day, but several ate more cannabis in the mornings, essentially getting up to 12 hours relief from a single edible dose.  A serendipitous side effect was that the cannabinoids also sped bone and nerve healing.

Another segment of the elderly population use ointments containing cannabis for relief from arthritis pain in their hands.  One used it on the lower back with success, while others got insufficient relief, possibly due to fatty tissues between the ointment and joints.

We truly need to de-schedule cannabis so that researchers can determine the plethora of health benefits from its use.

AuntieBS

Marijuana Use for HeartBergenfield, NJ: Heart failure patients with a history of cannabis use possess reduced odds of in-hospital mortality compared to similarly matched controls, according to data published online in the journal Circulation.

Investigators assessed data from over six million heart failure patients over a seven-year period. Patients with a history of cannabis use were less likely to suffer from atrial fibrillation (irregular heartbeat), experienced shorter hospital stays, and were less likely to die during hospitalization as compared to non-users.

“Our study showed that cannabis use lowered the odds of atrial fibrillation in patients with heart failure,” authors concluded. “There was also reduced in-hospital mortality among patients admitted for the primary diagnosis of heart failure in DU (cannabis dependent users) and NDU (non-dependent cannabis users) which was not explained by comorbid conditions and demographic data. This study provides important opportunity to explore the preventive mechanism of cannabis on atrial fibrillation and its therapeutic potential in heart failure patients.”

Prior studies have similarly reported increased survival rates among marijuana-positive patients hospitalized for traumaTBI (traumatic brain injury), and heart attacks.

For more information, contact Paul Armentano, NORML Deputy Director, at: paul@norml.org. Full text of the study, “Among patients with heart failure, cannabis is associated with reduced occurrence of atrial fibrillation and in-hospital mortality: Evidence from the Nationwide Survey 2007-2014.”

Survey: Many Medical Cannabis Patients Cease Using Opioids

Thursday, 16 November 2017

Medical Marijuana Less OpioidsChicago, IL: More than two out of three medical marijuana patients substitute cannabis in place of opioids, according to survey data compiled by Aclara Research, a Chicago-based consulting firm.

Sixty-seven percent of respondents reported that they ceased their opioid use after initiating cannabis therapy. Twenty-nine percent of respondents said that cannabis allowed them to decrease their use of opioids.

The findings are similar to those of prior surveys concluding that patients who use cannabis therapeutically typically reduce or cease their use of opioids and other prescription pharmaceuticals.

According to an October 21 academic paper published on SSRN.com, the enactment of medical marijuana access laws is associated with a $2.47 decrease in per person prescribed opioid spending among those between the ages of 18 and 39. Previous studies – such as those herehere, and here – have drawn similar conclusions.

On November 1, members of President Trump’s opioid commission rejected the notion that cannabis access is associated with reduced rates of opioid abuse and mortality. By contrast, the US National Institute on Drug Abuse acknowledges that available studies “cumulatively suggest that medical marijuana products may have a role in reducing the use of opioids.”

For more information, contact Paul Armentano, NORML Deputy Director, at: paul@norml.org.

Study: Oral THC Mitigates Symptoms Of Sleep Apnea

Thursday, 16 November 2017

THC and Sleep ApneaChicago, IL: The use of oral THC mitigates sleep apnea symptoms compared to placebo, according to clinical trial data published online ahead of print in the journal Sleep.

Investigators at the University of Illinois at Chicago assessed the efficacy of dronabinol treatment in 73 adults diagnosed with moderate to severe obstructive sleep apnea (OSA). They reported that oral THC administration prior to bedtime reduced symptom severity and improved subjective sleepiness.

The results of a prior clinical trial in 2013 similarly reported, “Dronabinol treatment may be a viable alternative or adjunctive therapy in selected patients with OSA.”

For more information, contact Paul Armentano, NORML Deputy Director, at: paul@norml.orgFull text of the study, “Pharmacotherapy of apnea by cannabimimetric enhancement, the PACE clinical trial: effects of dronabinol on obstructive sleep apnea,” appears in Sleep.